The most active researchers, institutions, and subtopics in Hemophilia, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 420 recent PubMed papers (2021-2026) matching "hemophilia gene therapy factor VIII". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Peyvandi Flora | Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | 19 |
| 2 | Miesbach Wolfgang | Medical Clinic 2 | 14 |
| 3 | Xue Feng | National Clinical Research Center for Blood Diseases | 14 |
| 4 | Yang Renchi | National Clinical Research Center for Blood Diseases | 14 |
| 5 | Zhang Lei | National Clinical Research Center for Blood Diseases | 13 |
| 6 | Mahlangu Johnny | Charlotte Maxeke Johannesburg Academic Hospital | 12 |
| 7 | Kaczmarek Radoslaw | Indiana University School of Medicine | 12 |
| 8 | Kenet Gili | Tel Aviv University | 10 |
| 9 | Liu Wei | National Clinical Research Center for Blood Diseases | 10 |
| 10 | Oldenburg Johannes | University Hospital Bonn | 9 |
| 11 | Wu Runhui | Beijing Children's Hospital | 9 |
| 12 | Symington Emily | Cambridge University Hospitals NHS Foundation Trust | 9 |
| 13 | Castaman Giancarlo | Careggi University Hospital | 9 |
| 14 | Fong Sylvia | Queen's University | 9 |
| 15 | Spencer H Trent | Emory University | 8 |
| 16 | Klamroth Robert | Vascular Medicine and Haemostaseology | 8 |
| 17 | Chambost Hervé | Children Hospital La Timone & Aix Marseille University | 8 |
| 18 | Madan Bella | Guy's and St Thomas' NHS Foundation Trust | 8 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene thera (2026) · PMID 42436858
Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies. (2026) · PMID 42415686
Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophi (2026) · PMID 42374266
One-stage Assay Factor VIII Activity Reflects AAV-Derived Factor VIII-Enhanced Thrombin Activation and Predicts Phenotype. (2026) · PMID 42371804
Shaping hemophilia care: lessons and legacy of the SIPPET trial after 10 years. (2026) · PMID 42305274
A full Hemophilia brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.